Results 81 to 90 of about 31,920 (182)
ABSTRACT Background Diagnosing chronic inflammatory demyelinating polyneuropathy (CIDP) relies on clinical and electrodiagnostic features. In 2021, the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) revised the CIDP guideline, superseding the 2010 European Federation of Neurological Societies (EFNS)/PNS guideline.
Iris N. van Doorn +11 more
wiley +1 more source
Vectors and Vector‐Borne Diseases: Biology, Epidemiology and Integrated Control Strategies
ABSTRACT Vector‐Borne Diseases (VBDs), transmitted by arthropods such as mosquitoes, ticks, fleas and sandflies, represent a significant threat to global health. These diseases can be caused by a variety of pathogens, including bacteria, viruses, protozoa, and helminths.
Roberta Rinaldi +4 more
wiley +1 more source
Fatal recurrent Guillain–Barré syndrome (GBS) in an Ethiopian male: a case report
Introduction Guillain–Barré syndrome (GBS) is a disease affecting the peripheral nerves, leading to a constellation of motor, sensory, and autonomic symptoms.
Eden Tesfaye Beyene +3 more
doaj +1 more source
Anesthesia for Cesarean Section in a Patient with Guillain-Barre Syndrome: Case Report
Background and objectives: Guillain-Barre syndrome during pregnancy is considered a rare neurological complication, and there is no consensus in literature for anesthetic management for cesarean section in such patients. The objective of this paper is to
Daniel Volquind +3 more
doaj +1 more source
Clinical implications of imlifidase interference in antibody screening and transfusion management
Abstract Background Imlifidase has received conditional approval from the EMA for desensitizing deceased donor kidney transplant recipients. It works by cleaving IgG into F(ab′)2 and Fc fragments, thereby reducing the risk of antibody‐mediated rejection. However, its impact on diagnostic assays remains understudied. Case Report We present the case of a
Zgjim Osmani +2 more
wiley +1 more source
The neurorehabilitation of people with Guillain-Barré Syndrome
Guillain-Barre Syndrome (GBS), or Acute Inflammatory Demyelinating Polyneuropathy (AIDP) is a rare, acquired condition which can cause pain, sensory impairment and weakness in the limbs.
Rachel Higgins +4 more
doaj +1 more source
Guillain-Barre syndrome is an acute rapid-onset progressive neurologic disorder over days to 4 weeks. It presents with symmetric weakness often starting in the legs as an ascending paralysis. Reflexes are reduced or absent early in the disease. The condition is immune-mediated by affecting myelin or axons acutely often triggered by preceding infections.
openaire +2 more sources
Coexistence of familial mediterranean fever and guillain barre syndrome
Familial Mediterranean Fever (FMF) is the most common autoinflammatory disease characterized by recurrent episodes of abdominal pain, fever and serositis. It is more common in countries around the Mediterranean. Guillain Barre Syndrome (GBS) is an acute,
İsmail Tunçekin, Murat Toprak
doaj +1 more source
Síndrome de Guillain-Barré posterior a infección por Varicela-Zoster
: Guillain-Barre Syndrome is the most common cause of acute polyradiculoneuropathology. It is an immunological illness, predominantly motor proximal, demyelining and inflammatory, and triggered by a viral or bacterial infectious process, surgery ...
Hernández Pernía Armando +4 more
doaj
Guillain-Barré syndrome is the most common acute inflammatory demyelinating peripheral nerve condition. Occasionally, other autoimmune conditions can mimic Guillain-Barré syndrome but may require different diagnostic workup and treatment.
Thomas Schulten +3 more
doaj +1 more source

